Filtros de búsqueda

Lista de obras de

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one

artículo científico publicado en 2016

A Population of Heterogeneous Breast Cancer Patient-Derived Xenografts Demonstrate Broad Activity of PARP Inhibitor in BRCA1/2 Wild-Type Tumors

artículo científico publicado en 2017

A Technical Assessment of the Utility of Reverse Phase Protein Arrays for the Study of the Functional Proteome in Non-microdissected Human Breast Cancers

artículo científico publicado en 2010

A decision support framework for genomically informed investigational cancer therapy

artículo científico publicado en 2015

A novel automated assay for the rapid identification of metastatic breast carcinoma in sentinel lymph nodes ⬇️

artículo científico publicado el 11 de enero de 2011

A phase 1 dose escalation, pharmacokinetic, and pharmacodynamic evaluation of eIF-4E antisense oligonucleotide LY2275796 in patients with advanced cancer

artículo científico publicado en 2011

A phase I study to assess the feasibility and oncologic safety of axillary reverse mapping in breast cancer patients

artículo científico publicado en 2010

A prospective study comparing touch imprint cytology, frozen section analysis, and rapid cytokeratin immunostain for intraoperative evaluation of axillary sentinel lymph nodes in breast cancer

artículo científico publicado en 2009

AB045. P-13. Genomic heterogeneity between Asian and Western intrahepatic cholangiocarcinoma

article

AB065. P-36. Debio 1347 in patients with cholangiocarcinoma harboring an FGFR gene alteration: preliminary results

article

ALK: a tyrosine kinase target for cancer therapy

artículo científico publicado en 2017

Aberrations in translational regulation are associated with poor prognosis in hormone receptor-positive breast cancer

artículo científico publicado en 2012

Ability to Generate Patient-Derived Breast Cancer Xenografts Is Enhanced in Chemoresistant Disease and Predicts Poor Patient Outcomes

artículo científico publicado en 2015

Abstract P2-12-13: Knowledge and Information seeking about personalized breast cancer therapy

Accelerated Approval and Breakthrough Therapy Designation: Oncology Drug Development on Speed? ⬇️

artículo científico publicado el 5 de julio de 2013

Accuracy and self correction of information received from an internet breast cancer list: content analysis

artículo científico publicado en 2006

Accuracy of physical examination, ultrasonography, and mammography in predicting residual pathologic tumor size in patients treated with neoadjuvant chemotherapy

artículo científico publicado en 2006

Accuracy of the combination of mammography and sonography in predicting tumor response in breast cancer patients after neoadjuvant chemotherapy

artículo científico publicado en 2006

Actionable mutations in plasma cell-free DNA in patients with advanced cancers referred for experimental targeted therapies

artículo científico publicado en 2015

Activated autologous dendritic cells injected intratumorally are able to overcome local and systemic immune suppression imposed by the tumor and its microenvironment.

artículo científico publicado en 2014

Activity of c-Met/ALK Inhibitor Crizotinib and Multi-Kinase VEGF Inhibitor Pazopanib in Metastatic Gastrointestinal Neuroectodermal Tumor Harboring EWSR1-CREB1 Fusion

artículo científico publicado en 2016

Adapting a natural language processing tool to facilitate clinical trial curation for personalized cancer therapy

artículo científico

Advances in targeting human epidermal growth factor receptor-2 signaling for cancer therapy

artículo científico publicado en 2006

Age and survival estimates in patients who have node-negative T1ab breast cancer by breast cancer subtype

artículo científico publicado en 2011

American College of Surgeons Oncology Group (ACOSOG) Z0011: impact on surgeon practice patterns

artículo científico publicado en 2012

Among women who experience a recurrence after postmastectomy radiation therapy irradiation is not associated with more aggressive local recurrence or reduced survival

artículo científico publicado en 2010

Analysis of 1,115 patients tested for MET amplification and therapy response in the MD Anderson Phase I Clinic.

artículo científico publicado en 2014

Analysis of MET genetic aberrations in patients with breast cancer at MD Anderson Phase I unit

artículo científico publicado en 2014

Anaphylactoid reactions to isosulfan blue dye during breast cancer lymphatic mapping in patients given preoperative prophylaxis

artículo científico publicado en 2004

Antiangiogenesis and gene aberration-related therapy may improve overall survival in patients with concurrent KRAS and TP53 hotspot mutant cancer

artículo científico publicado en 2017

Antitumor activity of rapamycin and octreotide as single agents or in combination in neuroendocrine tumors

artículo científico publicado en 2008

Association between clinical characteristics and risk-reduction interventions in women who underwent BRCA1 and BRCA2 testing: a single-institution study

artículo científico publicado en 2006

Association between new-onset hypothyroidism and clinical response in patients treated with tyrosine kinase inhibitor therapy in phase I clinical trials

artículo científico publicado en 2016

Association of SMAD4 mutation with patient demographics, tumor characteristics, and clinical outcomes in colorectal cancer

artículo científico publicado en 2017

Attitudes regarding privacy of genomic information in personalized cancer therapy

artículo científico publicado en 2014

Attitudes toward molecular testing for personalized cancer therapy

artículo científico publicado en 2014

Automated identification of molecular effects of drugs (AIMED)

artículo científico publicado en 2016

BRAF Mutation Testing in Cell-Free DNA from the Plasma of Patients with Advanced Cancers Using a Rapid, Automated Molecular Diagnostics System

artículo científico

BRAF V600E mutations in urine and plasma cell-free DNA from patients with Erdheim-Chester disease

artículo científico publicado en 2014

BRAF mutation testing with a rapid, fully integrated molecular diagnostics system

artículo científico publicado en 2015

BRIT1 regulates early DNA damage response, chromosomal integrity, and cancer

artículo científico publicado en 2006

Beta-blocker use is associated with improved relapse-free survival in patients with triple-negative breast cancer

artículo científico publicado en 2011

Beyond BRAF(V600): clinical mutation panel testing by next-generation sequencing in advanced melanoma

artículo científico publicado en 2014

Bias from removing read duplication in ultra-deep sequencing experiments

artículo científico publicado en 2014

BikDD eliminates breast cancer initiating cells and synergizes with lapatinib for breast cancer treatment

artículo científico publicado en 2011

Biliary cancer: Utility of next-generation sequencing for clinical management

artículo científico publicado en 2016

Biologic and immunologic effects of preoperative trastuzumab for ductal carcinoma in situ of the breast

artículo científico publicado en 2010

Biologic features and prognosis of ductal carcinoma in situ are not adversely impacted by initial large body mass ⬇️

artículo científico publicado el 4 de marzo de 2012

Biology, treatment, and outcome in very young and older women with DCIS.

artículo científico publicado en 2012

Biomarkers of Response to Akt Inhibitor MK-2206 in Breast Cancer ⬇️

artículo científico publicado el 29 de agosto de 2012

Breast cancer in the very elderly: treatment patterns and complications in a tertiary cancer center

artículo científico publicado en 2006

Breast cancer multifocality and multicentricity and locoregional recurrence

artículo científico publicado en 2013

Breast conservation in breast cancer: surgical and adjuvant considerations

artículo científico publicado en 2004

Building a Personalized Medicine Infrastructure at a Major Cancer Center ⬇️

artículo científico publicado el 15 de abril de 2013

CanDrA: cancer-specific driver missense mutation annotation with optimized features

artículo científico publicado en 2013

Cancer driver mutation prediction through Bayesian integration of multi-omic data.

artículo científico publicado en 2018

Cancer-Related Internet Use and its Association with Patient Decision Making and Trust in Physicians among Patients in an Early Drug Development Clinic

scholarly article published 8 March 2018

Career track of Society of University Surgeons Resident Research Award recipients

artículo científico publicado en 2013

Catalytic mTOR inhibitors can overcome intrinsic and acquired resistance to allosteric mTOR inhibitors ⬇️

artículo científico publicado en 2014

Challenges and perspective of drug repurposing strategies in early phase clinical trials

artículo científico publicado en 2015

Characteristics and outcomes for patients with advanced vaginal or vulvar cancer referred to a phase I clinical trials program: the MD Anderson cancer center experience

artículo científico publicado en 2015

Classification of Ipsilateral Breast Tumor Recurrences After Breast Conservation Therapy Can Predict Patient Prognosis and Facilitate Treatment Planning ⬇️

artículo científico publicado el 1 de marzo de 2011

ClinSeK: a targeted variant characterization framework for clinical sequencing

artículo científico publicado en 2015

Clinical Use of Precision Oncology Decision Support

artículo científico publicado en 2017

Clinical actionability enhanced through deep targeted sequencing of solid tumors

artículo científico publicado en 2015

Clinical activity of ceritinib in ROS1-rearranged non-small cell lung cancer: Bench to bedside report

artículo científico publicado en 2016

Clinical genomic profiling to identify actionable alterations for investigational therapies in patients with diverse sarcomas

artículo científico publicado en 2017

Clinical next generation sequencing to identify actionable aberrations in a phase I program

artículo científico publicado en 2015

Clinical outcome of patients with lymph node-negative breast carcinoma who have sentinel lymph node micrometastases detected by immunohistochemistry

artículo científico publicado en 2005

Clinical outcomes based on multigene profiling in metastatic breast cancer patients

artículo científico publicado en 2016

Clinically relevant inflammatory breast cancer patient-derived xenograft-derived ex vivo model for evaluation of tumor-specific therapies.

artículo científico publicado en 2018

Co-occurring Genomic Alterations and Association With Progression-Free Survival in BRAFV600-Mutated Nonmelanoma Tumors

artículo científico publicado en 2017

Colocalized delivery of rapamycin and paclitaxel to tumors enhances synergistic targeting of the PI3K/Akt/mTOR pathway

artículo científico publicado en 2014

Commonly cited website quality criteria are not effective at identifying inaccurate online information about breast cancer

artículo científico publicado en 2008

Comparative analysis of sentinel lymph node operation in male and female breast cancer patients

artículo científico publicado en 2006

Comparison of Akt/mTOR signaling in primary breast tumors and matched distant metastases

artículo científico publicado en 2008

Comprehensive Analysis of Alternative Splicing Across Tumors from 8,705 Patients

artículo científico

Comprehensive Characterization of Cancer Driver Genes and Mutations

article

Continuous anti-angiogenic therapy after tumor progression in patients with recurrent high-grade epithelial ovarian cancer: phase I trial experience

artículo científico publicado en 2016

Contralateral prophylactic mastectomy. Predictors of significant histologic findings

artículo científico publicado en 2004

Coordinated prophylactic surgical management for women with hereditary breast-ovarian cancer syndrome

artículo científico publicado en 2008

Correction to: 33rd Annual Meeting & Pre-Conference Programs of the Society for Immunotherapy of Cancer (SITC 2018)

article

Correction: Ability to Generate Patient-Derived Breast Cancer Xenografts Is Enhanced in Chemoresistant Disease and Predicts Poor Patient Outcomes

artículo científico publicado en 2016

Cyclooxygenase-2 expression in primary breast cancers predicts dissemination of cancer cells to the bone marrow.

artículo científico publicado en 2008

Cytologically proven axillary lymph node metastases are eradicated in patients receiving preoperative chemotherapy with concurrent trastuzumab for HER2-positive breast cancer

artículo científico publicado en 2010

Deciphering the role of PI3K/Akt/mTOR pathway in breast cancer biology and pathogenesis

artículo científico publicado en 2010

Decision analysis to assess the efficacy of routine sentinel lymphadenectomy in patients undergoing prophylactic mastectomy

artículo científico publicado en 2007

Decreased TGFbeta signaling and increased COX2 expression in high risk women with increased mammographic breast density

scientific article published on 25 February 2009

Delays in Primary Surgical Treatment Are Not Associated With Significant Tumor Size Progression in Breast Cancer Patients ⬇️

artículo científico publicado el 1 de julio de 2011

Determinants of rapamycin sensitivity in breast cancer cells

artículo científico publicado en 2004

Development and validation of an ultra-deep next-generation sequencing assay for testing of plasma cell-free DNA from patients with advanced cancer

artículo científico publicado en 2017

Differences in gene and protein expression and the effects of race/ethnicity on breast cancer subtypes

artículo científico publicado en 2013

Differential response to neoadjuvant chemotherapy among 7 triple-negative breast cancer molecular subtypes

artículo científico publicado en 2013

Disease-Free and Overall Survival Among Patients With Operable HER2-Positive Breast Cancer Treated With Sequential vs Concurrent Chemotherapy: The ACOSOG Z1041 (Alliance) Randomized Clinical Trial

Disseminated tumor cells in biologic subtypes of stage I-III breast cancer patients

artículo científico publicado en 2010

Does Blue Dye Contribute to Success of Sentinel Node Mapping for Breast Cancer? ⬇️

artículo científico publicado el 19 de septiembre de 2010

Dual targeting of AKT and mammalian target of rapamycin: a potential therapeutic approach for malignant peripheral nerve sheath tumor

artículo científico publicado en 2009

Earlier age of onset of BRCA mutation-related cancers in subsequent generations

artículo científico publicado en 2011

Effect of metformin on survival outcomes in diabetic patients with triple receptor‐negative breast cancer ⬇️

artículo científico publicado el 28 de julio de 2011

Effect of postmastectomy radiotherapy in patients <35 years old with stage II-III breast cancer treated with doxorubicin-based neoadjuvant chemotherapy and mastectomy

artículo científico publicado en 2007

Effect of primary tumor extirpation in breast cancer patients who present with stage IV disease and an intact primary tumor

artículo científico publicado en 2006

Effects of tissue handling on RNA integrity and microarray measurements from resected breast cancers

artículo científico publicado en 2011

Efficacy of RAD001 (everolimus) and octreotide LAR in advanced low- to intermediate-grade neuroendocrine tumors: results of a phase II study

artículo científico publicado en 2008

Efficacy of neoadjuvant therapy with trastuzumab concurrent with anthracycline‐ and nonanthracycline‐based regimens for HER2‐positive breast cancer ⬇️

artículo científico publicado el 27 de septiembre de 2011

Efficacy of quality criteria to identify potentially harmful information: a cross-sectional survey of complementary and alternative medicine web sites

artículo científico publicado en 2004

Emergence of constitutively active estrogen receptor-α mutations in pretreated advanced estrogen receptor-positive breast cancer

artículo científico publicado en 2014

Epithelial to mesenchymal transition is associated with rapamycin resistance

artículo científico publicado en 2015

Erratum: Actionable mutations in plasma cell-free DNA in patients with advanced cancers referred for experimental targeted therapies

artículo científico publicado en 2015

Evaluation of Novel Targeted Therapies in Aggressive Biology Sarcoma Patients after progression from US FDA approved Therapies

artículo científico publicado en 2016

Evaluation of Prexasertib, a Checkpoint Kinase 1 Inhibitor, in a Phase Ib Study of Patients with Squamous Cell Carcinoma

artículo científico publicado en 2018

Evaluation of a Breast Cancer Nomogram for Predicting Risk of Ipsilateral Breast Tumor Recurrences in Patients With Ductal Carcinoma in Situ After Local Excision ⬇️

artículo científico publicado el 17 de enero de 2012

Extracting genetic alteration information for personalized cancer therapy from ClinicalTrials.gov

artículo científico publicado en 2016

FBXW7 mutations in patients with advanced cancers: clinical and molecular characteristics and outcomes with mTOR inhibitors

artículo científico publicado en 2014

FGFR1β is a driver isoform of FGFR1 alternative splicing in breast cancer cells

Factors affecting the decision of breast cancer patients to undergo contralateral prophylactic mastectomy

artículo científico publicado en 2010

Factors predicting additional disease in the axilla in patients with positive sentinel lymph nodes after neoadjuvant chemotherapy

artículo científico publicado en 2008

False negative rate of sentinel lymph node biopsy in multicentric and multifocal breast cancers may be higher in cases with large additive tumor burden

artículo científico publicado en 2009

First-in-human trial of multikinase VEGF inhibitor regorafenib and anti-EGFR antibody cetuximab in advanced cancer patients

artículo científico publicado en 2017

Fluorouracil, epirubicin, and cyclophosphamide (FEC-75) followed by paclitaxel plus trastuzumab versus paclitaxel plus trastuzumab followed by FEC-75 plus trastuzumab as neoadjuvant treatment for patients with HER2-positive breast cancer (Z1041): a r

Frequency of mesenchymal-epithelial transition factor gene (MET) and the catalytic subunit of phosphoinositide-3-kinase (PIK3CA) copy number elevation and correlation with outcome in patients with early stage breast cancer

artículo científico publicado en 2012

Functional consequence of the MET-T1010I polymorphism in breast cancer

artículo científico publicado en 2015

Functional proteomics can define prognosis and predict pathologic complete response in patients with breast cancer

artículo científico publicado en 2011

Gene Expression, Molecular Class Changes, and Pathway Analysis after Neoadjuvant Systemic Therapy for Breast Cancer ⬇️

artículo científico publicado el 10 de enero de 2012

Genetic variants in the H2AFX promoter region are associated with risk of sporadic breast cancer in non-Hispanic white women aged <or=55 years

artículo científico publicado en 2007

Genotype inBRCA-associated Breast Cancers ⬇️

artículo científico publicado el 10 de diciembre de 2012

Genotype-Phenotype Correlations by Ethnicity and Mutation Location in BRCA Mutation Carriers

artículo científico publicado en 2015

HER2 status predicts the presence of circulating tumor cells in patients with operable breast cancer

artículo científico publicado en 2008

HER2 studies look promising ⬇️

artículo científico publicado el 15 de marzo de 2011

Hepatocellular carcinoma: Where there is unmet need

artículo científico publicado en 2015

Heterogeneous perivascular cell coverage affects breast cancer metastasis and response to chemotherapy

artículo científico publicado en 2016

High Intratumoral Stromal Content Defines Reactive Breast Cancer as a Low-risk Breast Cancer Subtype

artículo científico publicado en 2016

High prevalence of preinvasive lesions adjacent to BRCA1/2-associated breast cancers

artículo científico publicado en 2009

High risk of recurrence for patients with breast cancer who have human epidermal growth factor receptor 2-positive, node-negative tumors 1 cm or smaller

artículo científico publicado en 2009

High stearoyl-CoA desaturase 1 expression is associated with shorter survival in breast cancer patients

artículo científico publicado en 2013

High-resolution fiber optic microscopy with fluorescent contrast enhancement for the identification of axillary lymph node metastases in breast cancer: a pilot study ⬇️

artículo científico publicado el 16 de septiembre de 2010

Histologic changes associated with false-negative sentinel lymph nodes after preoperative chemotherapy in patients with confirmed lymph node-positive breast cancer before treatment

artículo científico publicado en 2010

Hormone receptor status influences the locoregional benefit of trastuzumab in patients with nonmetastatic breast cancer

scientific article published on 17 April 2012

Hotspot mutation panel testing reveals clonal evolution in a study of 265 paired primary and metastatic tumors

artículo científico publicado en 2015

Hotspot mutations delineating diverse mutational signatures and biological utilities across cancer types

artículo científico publicado en 2016

How many sentinel lymph nodes are enough during sentinel lymph node dissection for breast cancer? ⬇️

artículo científico publicado en 2008

Identification of frequent somatic mutations in inflammatory breast cancer

artículo científico publicado en 2017

Impact of Progression During Neoadjuvant Chemotherapy on Surgical Management of Breast Cancer ⬇️

artículo científico publicado el 1 de abril de 2011

Impact of chemotherapy sequencing on local-regional failure risk in breast cancer patients undergoing breast-conserving therapy

artículo científico publicado en 2013

Impact of internal mammary lymph node drainage identified by preoperative lymphoscintigraphy on outcomes in patients with stage I to III breast cancer ⬇️

artículo científico publicado el 30 de mayo de 2012

Impact of low estrogen/progesterone receptor expression on survival outcomes in breast cancers previously classified as triple negative breast cancers ⬇️

artículo científico publicado el 11 de agosto de 2011

Impact of the American College of Surgeons Oncology Group Z0011 Criteria Applied to a Contemporary Patient Population ⬇️

artículo científico publicado el 2 de noviembre de 2012

Implementation of biomarker-driven cancer therapy: existing tools and remaining gaps

artículo científico publicado en 2014

Implications of constructed biologic subtype and its relationship to locoregional recurrence following mastectomy

artículo científico publicado en 2012

Improving local control with breast-conserving therapy: a 27-year single-institution experience

artículo científico publicado en 2005

Incidence and consequence of close margins in patients with ductal carcinoma-in situ treated with mastectomy: is further therapy warranted?

artículo científico publicado en 2013

Incidence and outcome of BRCA mutations in unselected patients with triple receptor-negative breast cancer

artículo científico publicado en 2011

Incidence and prevention of venous thromboembolism in patients undergoing breast cancer surgery and treated according to clinical pathways

artículo científico publicado en 2006

Incidence of anaphylactoid reactions to isosulfan blue dye during breast carcinoma lymphatic mapping in patients treated with preoperative prophylaxis: results of a surgical prospective clinical practice protocol

artículo científico publicado en 2005

Incidence of infusion reactions to anti-neoplastic agents in early phase clinical trials: The MD Anderson Cancer Center experience

artículo científico publicado en 2016

Incorporation of sentinel lymph node metastasis size into a nomogram predicting nonsentinel lymph node involvement in breast cancer patients with a positive sentinel lymph node

artículo científico publicado en 2012

Influence of biospecimen variables on proteomic biomarkers in breast cancer

artículo científico publicado en 2014

Instruments to assess the quality of health information on the World Wide Web: what can our patients actually use?

artículo científico publicado en 2005

Intra-individual comparison of lymphatic drainage patterns using subareolar and peritumoral isotope injection for breast cancer

artículo científico publicado en 2009

Intracellular signaling in tumor and endothelial cells: The expected and, yet again, the unexpected

artículo científico publicado en 2006

Intramammary lymph node metastases are an independent predictor of poor outcome in patients with breast carcinoma

artículo científico publicado en 2004

Is intraoperative touch imprint cytology of sentinel lymph nodes in patients with breast cancer cost effective?

artículo científico publicado en 2006

Is the future of personalized therapy in triple-negative breast cancer based on molecular subtype?

artículo científico publicado en 2015

Landscape of DNA virus associations across human malignant cancers: analysis of 3,775 cases using RNA-Seq

artículo científico publicado en 2013

Liquid Biopsies Using Plasma Exosomal Nucleic Acids and Plasma Cell-Free DNA Compared with Clinical Outcomes of Patients with Advanced Cancers

artículo científico publicado en 2017

Local, regional, and systemic recurrence rates in patients undergoing skin‐sparing mastectomy compared with conventional mastectomy ⬇️

artículo científico publicado el 13 de octubre de 2010

Local-regional control according to surrogate markers of breast cancer subtypes and response to neoadjuvant chemotherapy in breast cancer patients undergoing breast conserving therapy ⬇️

artículo científico publicado el 23 de mayo de 2012

Locoregional Interaction of Ixabepilone (Ixempra) After Breast Cancer Radiation ⬇️

artículo científico publicado el 12 de febrero de 2013

Loss of HER2 amplification following trastuzumab-based neoadjuvant systemic therapy and survival outcomes

artículo científico publicado en 2009

Lymphovascular invasion and lobular histology are associated with increased incidence of isolated tumor cells in sentinel lymph nodes from early-stage breast cancer patients

artículo científico publicado en 2008

MET aberrations and c-MET inhibitors in patients with gastric and esophageal cancers in a phase I unit

artículo científico publicado en 2014

MET abnormalities in patients with genitourinary malignancies and outcomes with c-MET inhibitors

artículo científico publicado en 2014

MET amplification in metastatic colorectal cancer: an acquired response to EGFR inhibition, not a de novo phenomenon

artículo científico publicado en 2016

MET nucleotide variations and amplification in advanced ovarian cancer: characteristics and outcomes with c-Met inhibitors

artículo científico publicado en 2013

MK-2206 window of opportunity study in breast cancer.

artículo científico publicado en 2018

Magnetic resonance imaging as a predictor of pathologic response in patients treated with neoadjuvant systemic treatment for operable breast cancer. Translational Breast Cancer Research Consortium trial 017.

scientific article published on 21 February 2013

Mammalian target of rapamycin

artículo científico publicado en 2004

Margin assessment after neoadjuvant chemotherapy in invasive lobular cancer

artículo científico publicado en 2009

Metformin and pathologic complete responses to neoadjuvant chemotherapy in diabetic patients with breast cancer

artículo científico publicado en 2009

Metformin: a therapeutic opportunity in breast cancer

artículo científico publicado en 2010

Modifying the Clinical Research Infrastructure at a Dedicated Clinical Trials Unit: Assessment of Trial Development, Activation, and Participant Accrual

artículo científico publicado en 2016

Molecular therapeutics: promise and challenges

artículo científico publicado en 2004

Molecular‐targeted nanotherapies in cancer: Enabling treatment specificity ⬇️

artículo científico publicado el 25 de octubre de 2011

Multiclonal Invasion in Breast Tumors Identified by Topographic Single Cell Sequencing

artículo científico publicado en 2017

Multidisciplinary considerations in the implementation of the findings from the American College of Surgeons Oncology Group (ACOSOG) Z0011 study: a practice-changing trial

artículo científico publicado en 2011

Multigene clinical mutational profiling of breast carcinoma using next-generation sequencing

artículo científico publicado en 2015

Multistage delivery of chemotherapeutic nanoparticles for breast cancer treatment ⬇️

artículo científico publicado el 31 de julio de 2012

Mutation profiling in cholangiocarcinoma: prognostic and therapeutic implications

artículo científico publicado en 2014

Mutation-Enrichment Next-Generation Sequencing for Quantitative Detection of KRAS Mutations in Urine Cell-Free DNA from Patients with Advanced Cancers

artículo científico

Nanomedicine in cancer therapy: Innovative trends and prospects ⬇️

artículo científico publicado el 3 de mayo de 2011

Neoadjuvant chemotherapy in invasive lobular carcinoma may not improve rates of breast conservation

artículo científico publicado en 2009

Next generation sequencing analysis of platinum refractory advanced germ cell tumor sensitive to Sunitinib (Sutent®) a VEGFR2/PDGFRβ/c-kit/ FLT3/RET/CSF1R inhibitor in a phase II trial

artículo científico publicado en 2014

Nodal Status and Clinical Outcomes in a Large Cohort of Patients With Triple-Negative Breast Cancer ⬇️

artículo científico publicado el 23 de mayo de 2011

Novel algorithmic approach predicts tumor mutation load and correlates with immunotherapy clinical outcomes using a defined gene mutation set.

artículo científico publicado en 2016

Other primary malignancies in breast cancer patients treated with breast conserving surgery and radiation therapy

scientific article published on 06 December 2012

Outcome analysis of Phase I trial patients with metastatic and/or mutant non-small cell lung cancer

Outcome of triple-negative breast cancer in patients with or without deleterious BRCA mutations

artículo científico publicado en 2011

Outcomes of Post Mastectomy Radiation Therapy in Patients Receiving Axillary Lymph Node Dissection After Positive Sentinel Lymph Node Biopsy

artículo científico publicado en 2016

Outcomes of Sentinel Lymph Node-Positive Breast Cancer Patients Treated with Mastectomy Without Axillary Therapy

artículo científico publicado en 2016

Outcomes of breast-conservation therapy for invasive lobular carcinoma are equivalent to those for invasive ductal carcinoma

artículo científico publicado en 2006

Outcomes of phase I clinical trials for patients with advanced pancreatic cancer: update of the MD Anderson Cancer Center experience

artículo científico publicado en 2017

Overcoming implementation challenges of personalized cancer therapy

artículo científico publicado en 2012

PD-L1 expression in triple-negative breast cancer

scientific article published on 10 January 2014

PIK3CA/PTEN Mutations and Akt Activation As Markers of Sensitivity to Allosteric mTOR Inhibitors ⬇️

artículo científico publicado el 15 de marzo de 2012

Pathogenic Germline Variants in 10,389 Adult Cancers

artículo científico publicado en 2018

Perception of screening and risk reduction surgeries in patients tested for a BRCA deleterious mutation

artículo científico publicado en 2009

Personalized cancer therapy: leveraging a knowledge base for clinical decision-making

artículo científico publicado en 2017

Phase I clinical trial of combination imatinib and ipilimumab in patients with advanced malignancies

artículo científico publicado en 2017

Phase I dose escalation study of temsirolimus in combination with metformin in patients with advanced/refractory cancers.

artículo científico publicado en 2016

Phase I dose-escalation study of the mTOR inhibitor sirolimus and the HDAC inhibitor vorinostat in patients with advanced malignancy

artículo científico publicado en 2016

Phase I study of the anti-IGF1R antibody cixutumumab with everolimus and octreotide in advanced well-differentiated neuroendocrine tumors

artículo científico publicado en 2015

Phase I study of the combination of crizotinib (as a MET inhibitor) and dasatinib (as a c-SRC inhibitor) in patients with advanced cancer

artículo científico publicado en 2017

Phase IB Study of Vemurafenib in Combination with Irinotecan and Cetuximab in Patients with Metastatic Colorectal Cancer with BRAFV600E Mutation

artículo científico publicado en 2016

Phase II Randomized Study of Ixabepilone Versus Observation in Patients With Significant Residual Disease After Neoadjuvant Systemic Therapy for HER2-Negative Breast Cancer

artículo científico publicado en 2015

Phase Ib/II Study of the Safety and Efficacy of Combination Therapy with Multikinase VEGF Inhibitor Pazopanib and MEK Inhibitor Trametinib In Advanced Soft Tissue Sarcoma

artículo científico publicado en 2017

Physician recommendations regarding tamoxifen and patient utilization of tamoxifen after surgery for ductal carcinoma in situ

artículo científico publicado en 2004

Ploidy-Seq: inferring mutational chronology by sequencing polyploid tumor subpopulations

artículo científico publicado en 2015

Polymorphisms and haplotypes of the NBS1 gene are associated with risk of sporadic breast cancer in non-Hispanic white women <or=55 years

artículo científico publicado en 2006

Post-Discharge Survival Outcomes of Patients with Advanced Cancer from the University of Texas MD Anderson Cancer Center Investigational Cancer Therapeutics (Phase I Trials) Inpatient Unit

artículo científico publicado en 2016

Potential applicability of balloon catheter-based accelerated partial breast irradiation after conservative surgery for breast carcinoma

artículo científico publicado en 2004

Potential role of mammalian target of rapamycin inhibitors in breast cancer therapy

artículo científico publicado en 2005

Predicting outcomes in patients with advanced non-small cell lung cancer enrolled in early phase immunotherapy trials.

artículo científico publicado en 2018

Predictive factors for BRCA1/BRCA2 mutations in women with ductal carcinoma in situ ⬇️

artículo científico publicado el 25 de agosto de 2011

Predictors of systemic recurrence and disease-specific survival after ipsilateral breast tumor recurrence

artículo científico publicado en 2005

Predictors of tumor progression during neoadjuvant chemotherapy in breast cancer

artículo científico publicado en 2010

Presence of both alterations in FGFR/FGF and PI3K/AKT/mTOR confer improved outcomes for patients with metastatic breast cancer treated with PI3K/AKT/mTOR inhibitors

artículo científico publicado en 2016

Present-day locoregional control in patients with t1 or t2 breast cancer with 0 and 1 to 3 positive lymph nodes after mastectomy without radiotherapy

artículo científico publicado en 2010

Prevalence of MDM2 amplification and coalterations in 523 advanced cancer patients in the MD Anderson phase 1 clinic

Prevalence of actionable mutations and copy number alterations and the price of a genomic testing panel

artículo científico publicado en 2016

Primary Tumor Extirpation in Breast Cancer Patients Who Present with Stage IV Disease is Associated with Improved Survival ⬇️

artículo científico publicado el 11 de enero de 2013

Prior systemic treatment increased the incidence of somatic mutations in metastatic breast cancer

artículo científico publicado en 2017

Prognostic significance of HER-2 status in women with inflammatory breast cancer

artículo científico publicado en 2008

Promising rationally derived combination therapy with PI3K and CDK4/6 inhibitors.

artículo científico publicado en 2014

Prospective blinded study of BRAFV600E mutation detection in cell-free DNA of patients with systemic histiocytic disorders

artículo científico publicado en 2014

Prospective evaluation of the nipple-areola complex sparing mastectomy for risk reduction and for early-stage breast cancer

artículo científico publicado en 2011

Prospective randomized trial of paravertebral block for patients undergoing breast cancer surgery

artículo científico publicado en 2009

Punctuated copy number evolution and clonal stasis in triple-negative breast cancer

scientific article published on 15 August 2016

PurityEst: estimating purity of human tumor samples using next-generation sequencing data

artículo científico publicado en 2012

RET fusion as a novel driver of medullary thyroid carcinoma

artículo científico publicado en 2014

RNA-binding specificity of Y-box protein 1.

artículo científico publicado en 2009

Radiation dose escalation for loco-regional recurrence of breast cancer after mastectomy

artículo científico publicado en 2013

Radiation use and long-term survival in breast cancer patients with T1, T2 primary tumors and one to three positive axillary lymph nodes

artículo científico publicado en 2008

Rak functions as a tumor suppressor by regulating PTEN protein stability and function

artículo científico publicado en 2009

Rapamycin regulates stearoyl CoA desaturase 1 expression in breast cancer

artículo científico publicado en 2010

Rapamycin regulates the phosphorylation of rictor

artículo científico publicado en 2007

Receptor status change from primary to residual breast cancer after neoadjuvant chemotherapy and analysis of survival outcomes.

artículo científico publicado en 2014

Regulation and localization of ribosomal protein S6 kinase 1 isoforms

artículo científico publicado en 2009

Reliability and Evaluation of Health Information Online

Reliability and Evaluation of Health Information Online

Reliability and Evaluation of Health Information Online

article

Resection of liver metastases from breast cancer: estrogen receptor status and response to chemotherapy before metastasectomy define outcome

artículo científico publicado en 2012

Residual tumor thickness at the tumor-normal tissue interface predicts the recurrence-free survival in patients with liver metastasis of breast cancer

artículo científico publicado en 2014

Response to Neoadjuvant Systemic Therapy for Breast Cancer in BRCA Mutation Carriers and Noncarriers: A Single-Institution Experience ⬇️

artículo científico publicado el 6 de septiembre de 2011

Risk of Ipsilateral and Contralateral Cancer in BRCA Mutation Carriers with Breast Cancer

artículo científico publicado en 2011

Role of glycogen synthase kinase 3beta in rapamycin-mediated cell cycle regulation and chemosensitivity

artículo científico publicado en 2005

Role of primary tumor characteristics in predicting positive sentinel lymph nodes in patients with ductal carcinoma in situ or microinvasive breast cancer

artículo científico publicado en 2008

SU2C phase Ib study of paclitaxel and MK-2206 in advanced solid tumors and metastatic breast cancer

artículo científico publicado en 2015

Searching for cancer-related information online: unintended retrieval of complementary and alternative medicine information

artículo científico publicado en 2005

Selinexor (KPT-330) demonstrates anti-tumor efficacy in preclinical models of triple-negative breast cancer

artículo científico publicado en 2017

Sentinel lymph node surgery after neoadjuvant chemotherapy is accurate and reduces the need for axillary dissection in breast cancer patients

artículo científico publicado en 2009

Signature program: a platform of basket trials.

artículo científico publicado en 2018

Somatic mutations, clinicopathologic characteristics, and survival in patients with untreated breast cancer with bone-only and non-bone sites of first metastasis

Surgical patterns of care in patients with invasive breast cancer treated with neoadjuvant systemic therapy and breast magnetic resonance imaging: results of a secondary analysis of TBCRC 017.

artículo científico publicado en 2014

Survival of patients with metastatic leiomyosarcoma: the MD Anderson Clinical Center for targeted therapy experience

artículo científico publicado en 2016

Targeted Therapy for Advanced Solid Tumors on the Basis of Molecular Profiles: Results From MyPathway, an Open-Label, Phase IIa Multiple Basket Study

artículo científico publicado en 2018

Targeting TRK family proteins in cancer

artículo científico publicado en 2017

Targeting mammalian target of rapamycin synergistically enhances chemotherapy-induced cytotoxicity in breast cancer cells

artículo científico publicado en 2004

Targeting the PI3-kinase/Akt/mTOR signaling pathway

artículo científico publicado en 2013

Targeting the PI3K pathway in cancer: are we making headway?

artículo científico publicado en 2018

Targeting the PI3K/AKT/mTOR Pathway for the Treatment of Mesenchymal Triple-Negative Breast Cancer: Evidence From a Phase 1 Trial of mTOR Inhibition in Combination With Liposomal Doxorubicin and Bevacizumab

artículo científico publicado en 2016

Targeting the mTOR signaling network for cancer therapy

artículo científico publicado en 2009

Targeting translation initiation in breast cancer

artículo científico publicado en 2014

Targeting tyrosine-kinases and estrogen receptor abrogates resistance to endocrine therapy in breast cancer

artículo científico publicado en 2014

Ten-year recurrence rates in young women with breast cancer by locoregional treatment approach

artículo científico publicado en 2008

The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma

article

The Effect of Leucine Restriction on Akt/mTOR Signaling in Breast Cancer Cell Lines In Vitro and In Vivo ⬇️

artículo científico publicado el 1 de enero de 2011

The Impact of Tumor Heterogeneity on Patient Treatment Decisions ⬇️

artículo científico publicado el 9 de noviembre de 2012

The effect of ethnicity on immediate reconstruction rates after mastectomy for breast cancer

artículo científico publicado en 2004

The impact of immediate breast reconstruction on the technical delivery of postmastectomy radiotherapy

artículo científico publicado en 2006

The impact of pregnancy on breast cancer outcomes in women<or=35 years

artículo científico publicado en 2009

The rapamycin-regulated gene expression signature determines prognosis for breast cancer

artículo científico publicado en 2009

The right drugs at the right time for the right patient: the MD Anderson precision oncology decision support platform

artículo científico publicado en 2015

The role of surgeons in building a personalized medicine program

artículo científico publicado en 2015

Toward nodal staging of axillary lymph node basins through intradermal administration of fluorescent imaging agents

scientific article published on 13 December 2013

TransVar: a multilevel variant annotator for precision genomics

artículo científico publicado en 2015

Trends in and outcomes from sentinel lymph node biopsy (SLNB) alone vs. SLNB with axillary lymph node dissection for node-positive breast cancer patients: experience from the SEER database

artículo científico publicado en 2010

Triple receptor-negative breast cancer: the effect of race on response to primary systemic treatment and survival outcomes

artículo científico publicado en 2008

Triple-negative breast cancer is not a contraindication for breast conservation

artículo científico publicado en 2011

Triple-negative breast cancer patients treated at MD Anderson Cancer Center in phase I trials: improved outcomes with combination chemotherapy and targeted agents

artículo científico publicado en 2014

Two birds with one stone: octreotide treatment for acromegaly and breast cancer

artículo científico publicado en 2013

Unique molecular signatures as a hallmark of patients with metastatic breast cancer: implications for current treatment paradigms

artículo científico publicado en 2014

Usability of quality measures for online health information: Can commonly used technical quality criteria be reliably assessed?

artículo científico publicado en 2005

Use of Expansion Cohorts in Phase I Trials and Probability of Success in Phase II for 381 Anticancer Drugs

artículo científico publicado en 2017

Using Ontology Fingerprints to disambiguate gene name entities in the biomedical literature

artículo científico publicado en 2015

Validation of a breast cancer nomogram for predicting nonsentinel lymph node metastases after a positive sentinel node biopsy

artículo científico publicado en 2006

Validation of prognostic scoring and assessment of clinical benefit for patients with bone sarcomas enrolled in phase I clinical trials

artículo científico publicado en 2016

Vascular endothelial growth factor targeted therapy in the perioperative setting: implications for patient care

artículo científico publicado en 2010

Weekly nab-Rapamycin in patients with advanced nonhematologic malignancies: final results of a phase I trial

artículo científico publicado en 2013

Whole Genome Sequencing in Cancer Clinics

artículo científico publicado en 2014

cMET and phospho-cMET protein levels in breast cancers and survival outcomes

artículo científico publicado en 2012

eIF4E knockdown decreases breast cancer cell growth without activating Akt signaling

artículo científico publicado en 2008

mTOR Inhibitors Suppress Homologous Recombination Repair and Synergize with PARP Inhibitors via Regulating SUV39H1 in BRCA-Proficient Triple-Negative Breast Cancer

artículo científico publicado en 2015

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda